PCLOF (PharmaCielo) Common Stock: $121.89 Mil (As of Dec. 2025)


What is PharmaCielo Common Stock?

PharmaCielo PCLOF -4.35% Common Stock is $121.89 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

PharmaCielo's quarterly common stock declined from Jun. 2025 ($123.03 Mil) to Sep. 2025 ($121.55 Mil) but then increased from Sep. 2025 ($121.55 Mil) to Dec. 2025 ($121.89 Mil).

PharmaCielo's annual common stock declined from Dec. 2021 ($122.14 Mil) to Dec. 2022 ($119.04 Mil) but then increased from Dec. 2022 ($119.04 Mil) to Dec. 2023 ($123.72 Mil).

PharmaCielo Common Stock Historical Data

* Premium members only.

The historical data trend for PharmaCielo's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCielo Common Stock Chart

PharmaCielo Annual Data
Trend Aug17 Aug18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial 88.71 107.80 122.14 119.04 123.72

PharmaCielo Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 122.60 117.23 123.03 121.55 121.89

PharmaCielo Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $121.89 Mil mean?
PharmaCielo (PCLOF) has a Common Stock of $121.89 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on PharmaCielo and its competitors.
Is PharmaCielo's Common Stock too high?
PharmaCielo's current Common Stock is $121.89 Mil.
How does PharmaCielo's Common Stock compare to ZTS?
PharmaCielo's Common Stock of $121.89 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on PharmaCielo and its competitors. PharmaCielo's current Common Stock is $121.89 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCielo stock overvalued right now?
Based on GuruFocus' analysis, PharmaCielo (PCLOF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.10, compared to a current price of $0.05 — trading 48.5% below its estimated fair value. The current Common Stock is $121.89 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For PharmaCielo (PCLOF), the current Common Stock is $121.89 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaCielo Business Description

Other Exchanges PCLO:Canada
Address 82 Richmond Street East, Suite 805, Toronto, ON, CAN, M5C 1P1
PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. It is licensed to produce both CBD-dominant and THC-dominant cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico and generates the majority of its revenue in the form of the Sale of Cannabis derivative products in America followed by Australia, Africa and Europe.